Is Bristol-Myers Squibb A Better Bet Than Amgen?
- Thursday, July 9, 2020, 7:34
- Market
- Add a comment
Bristol-Myers Squibb’s stock has declined 2% since early February after the WHO declared the coronavirus a global health emergency, while Amgen stock has fared much better and gained 19% of its value. The spread of Covid-19 in various parts of the world has had a negative impact on the pharma…
About the Author
admin123 has written 23519 stories on this site.
